GlassScriptPhysician profile
Adam Back
NPI 1447540935
$98,879.62
in general payments reported to CMS, 2019-2025
14 companies · $11K in 2025
The $11K reported for 2025 was more than what 86% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $43K · 2020: $3,074 · 2021: $8,572 · 2022: $5,894 · 2023: $15K · 2024: $12K · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $18K · Travel and Lodging: $13K · Food and Beverage: $4,029 · Consulting Fee: $3,250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $18,113.25 |
| Travel and Lodging | $12,716.65 |
| Food and Beverage | $4,028.88 |
| Consulting Fee | $3,250.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $68,157.34 | 2019-2025 | Creo S2ai, Creo, Alif |
| Nuvasive, INC. | $19,050.34 | 2019-2023 | Xlif, Pulse, Reline |
| Alphatec Spine, INC | $6,651.62 | 2023-2025 | Other - Miscellaneous, Identiti |
| Boston Scientific Corporation | $1,603.21 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Superion Indirect Decompression System |
| Providence Medical Technology, INC. | $1,203.07 | 2019-2022 | |
| Si-Bone, INC. | $876.88 | 2024 | |
| Medtronic, INC. | $446.08 | 2023-2024 | Intellis Adaptivestim, Navlock, Catalyft Pl Expandable Interbody System |
| Orthofix Medical, INC. | $305.59 | 2024 | Northstar, Mariner |
| Spineology INC. | $279.97 | 2023 | Optimesh Expandable Interbody Fusion System |
| Zimvie INC. | $128.37 | 2023 | |
| Osteocentric Technologies, INC. | $99.50 | 2023 | Osteocentric 4.0 X 130mm Locking Bone Screw Fastener St |
| Aesculap, INC. | $41.04 | 2022 | |
| Brainlab, INC. | $19.51 | 2019 | |
| Abbott Laboratories | $17.10 | 2025 | Penta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Back listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.